BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Compounds/Empagliflozin
✓ FULLY PROFILED

Empagliflozin

996+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Empagliflozin 2D molecular structure
PubMed Studies
996+
Targets
2
Pathways
10
Molecular Targets
SLC5A1SLC5A2

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways
GLUCOSE_METABOLISMINSULIN_SIGNALINGINFLAMMATIONLIPID_METABOLISMNITRIC_OXIDEGUT_MICROBIOMECALCIUM_SIGNALINGEPIGENETICSAMPKIMMUNE_FUNCTION

Biological pathways associated with Empagliflozin based on target analysis.

Biological Mechanisms
IRSInsulin SignalingNF-κBNF-κBNONitric OxideNGFNeuroplasticitySIRT1SIRT1AMPKAMPKNLRP3NLRP3 Inflammasome

Biological mechanisms activated or modulated by Empagliflozin based on pathway and target analysis.

Health Goals
Longevity →Energy →Inflammation →Immune Support →Endurance →

Health goals where Empagliflozin ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions
Type 2 Diabetes →Metabolic Syndrome →Chronic Inflammation →Arthritis →Obesity →

Health conditions associated with the biological pathways influenced by Empagliflozin.

External References
PubChem CID 11949646 →996 PubMed studies →
Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Empagliflozin →
Data Source
Corpusv20260307-01
PubMed studies996
PubChem CID11949646
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Empagliflozin is generated from 996 PubMed-indexed studies. Key molecular targets include SLC5A1, SLC5A2. Associated biological pathways: GLUCOSE_METABOLISM, INSULIN_SIGNALING, INFLAMMATION. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.